Unfortunately no news or hints regarding 3D printing involvement or injection moulding manufacture. Also despite the company predictions of rising revenue and falling costs, the quarterly reveals falling customer receipts (- 52%) and rising research costs (+9%) and rising staff costs (+6.5%) as well as another CR due before end of CY24.
Enough for me to leave AVR on the watch list, waiting for a more suitable entry, until there's some news or trading improves.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M | |||
| Open | High | Low | Value | Volume |
| $16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $15.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 700 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |